-
West must embrace 'national power' or face decline: Rubio
-
Kyiv 'cannot agree' to EU membership limiting food exports: minister
-
Shell refining margins reach record highs as wars hit supply
-
Arteta targets more Arsenal glory after signing new deal until 2030
-
Former Spain, Barca winger Pedro retires from football
-
Russell hit with Singapore grid penalty for taking new power unit
-
Arteta signs new Arsenal deal until 2030
-
Spotify expands audiobooks to more than 180 markets
-
Stocks decline as oil climbs on Mideast flareup
-
French-Japanese duo wins chemistry Nobel for solving molecular 'mystery'
-
Gauff says online abuse was 'draining' after China Open exit
-
England's Nations League surge helps heal World Cup wounds
-
As sector struggles, Porsche puts luxury ahead of volume
-
Mayor of opposition stronghold Izmir defects to Erdogan party
-
'It's personal': Fiji minister pushes better climate finance at pre-COP
-
Mertens beats Gauff to set up Swiatek clash at China Open
-
Russia glosses over dark Soviet past in reinvented museum
-
Benin full of pride at role in Messi's last dance
-
UK tax body opened probe into Man City in 2018: FT
-
France suspends stun grenade use at student protests ahead of PM speech
-
Yemen's Houthis claim new attacks on Saudi airports as conflict deepens
-
Indonesian court hears 'negligence' complaint against state over fires, haze
-
Germany factory production at highest level for 18 months
-
Rubio in Greece to urge against Western civilisation 'decline'
-
Thailand floods death toll rises to 60 since mid-September
-
Micron workers at Taiwan plant vote in favour of strike
-
US pushes Russia for information on plague reports
-
In 'The Social Reckoning,' Jeremy Allen White takes on Facebook's 'frightening' ambition
-
Myanmar leader lands in Malaysia for migrant return talks
-
Chip industry activists call for South Korea to recognise cancer cases
-
Indian central bank hikes rates for first time since 2023
-
Famine-scarred southern Madagascar braces for El Nino
-
US military on Okinawa face curfew, alcohol ban after murder case
-
How the EU regulates lobbyists
-
Fierce lobbying in EU over 'forever chemicals'
-
I.Coast refuge offers lifelong care for youngsters scorned as 'sorcerers'
-
Dodgers beat Braves and Padres avoid sweep in MLB playoffs
-
Indian central bank hikes rates for first time in more than 3 years
-
Mourning, war and elections as Israel marks October 7
-
Hotel Blacklist Launches New Accommodation Industry Risk Assessment Tool
-
Messi says Argentina retirement is 'saddest day of my career'
-
Bangladesh nuclear plant draws hope -- and worry
-
Oil rises and stocks fall as Hormuz worries flare
-
US beat Canada 1-0 to wrap up four-win international break
-
Pacific presses world for help 'surviving' climate change at pre-COP summit
-
Turkey, Australia's joint COP31 leadership raises doubts
-
Verstappen revival to be put to the test in steamy Singapore
-
For Turkish NGOs, COP31 offers rare space for action
-
US woman who survived botched execution is conscious, speaking: lawyers
-
Sleep, appetite, gene-editing experts contend for Nobel chemistry prize
Landmark agreement reached at WHO over tackling future pandemics
Years of negotiations culminated in the wee small hours of Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding a repeat of the mistakes made during the Covid-19 crisis.
After more than three years of talks and a final marathon session, weary delegates at the World Health Organization's headquarters could finally pop the champagne corks at around 2:00 am (0000 GMT) Wednesday.
"The nations of the world made history in Geneva today," WHO chief Tedros Adhanom Ghebreyesus said in a statement.
"In reaching consensus on the Pandemic Agreement, not only did they put in place a generational accord to make the world safer, they have also demonstrated that multilateralism is alive and well, and that in our divided world, nations can still work together to find common ground, and a shared response to shared threats."
Five years after Covid-19 killed millions of people and devastated economies, a growing sense of urgency hung over the talks at a time when new health threats ranging from H5N1 bird flu to measles, mpox and Ebola were lurking.
The final stretch of negotiations also took place with cuts to US foreign aid spending and threatened tariffs on pharmaceuticals casting a new shadow over the talks.
- 'It's adopted' -
Right until the last minute, disagreement had lingered over a few thorny issues.
Negotiators had stumbled over the agreement's Article 11, which deals with transferring technology for pandemic health products, sources told AFP.
During the Covid-19 pandemic, poorer countries accused rich nations of hoarding vaccines and tests.
Countries that have large pharmaceutical industries have strenuously opposed the idea of mandatory tech transfers, insisting they be voluntary.
It appeared the tech transfer obstacle could be overcome by adding that any transfer needed to be "mutually agreed".
In the end, the 32-page agreement was entirely highlighted in green, indicating it had been fully approved by WHO member states.
"It's adopted," Anne-Claire Amprou, co-chair of the negotiations, announced to thundering applause.
The finalised text will now be presented for sign-off at the WHO's annual assembly next month.
As intense talks in corridors and closed rooms continued at the WHO headquarters, Tedros joined the negotiations late Tuesday and told reporters he thought the current draft was "good", "balanced" and that a deal would bring "more equity".
While taking measures to coordinate pandemic prevention, preparedness and response could be costly, Tedros insisted that "the cost of inaction is much bigger".
"Virus is the worst enemy. (It) could be worse than a war," he said.
The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was not present. US President Donald Trump ordered a withdrawal from the United Nations' health agency and from the pandemic agreement talks after taking office in January.
However, the US absence, and Trump's threat to slap steep tariffs on pharmaceutical products, still hung over the talks, making manufacturers and governments more jittery.
But in the end, countries reached consensus.
"The world is watching us, and you can be very proud of what you have just achieved," Amprou said.
J.Saleh--SF-PST